Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03981796
Title A Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Recruitment Active, not recruiting
Gender female
Phase Phase III
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

endometrial cancer

Therapies

Carboplatin + Paclitaxel

Carboplatin + Dostarlimab-gxly + Paclitaxel

Age Groups: adult | senior
Covered Countries USA | ITA | ESP | DEU | CAN | BEL

Facility Status City State Zip Country Details
GSK Investigational Site Mesa Arizona 85284 United States Details
GSK Investigational Site Phoenix Arizona 85016 United States Details
GSK Investigational Site Tucson Arizona 85704 United States Details
GSK Investigational Site Tucson Arizona 85710 United States Details
GSK Investigational Site Newport Beach California 92663 United States Details
GSK Investigational Site Palo Alto California 94304 United States Details
GSK Investigational Site Deerfield Beach Florida 33442 United States Details
GSK Investigational Site Jacksonville Florida 32207 United States Details
GSK Investigational Site Miami Florida 33136 United States Details
GSK Investigational Site Miami Florida 33176 United States Details
GSK Investigational Site Orlando Florida 32804 United States Details
GSK Investigational Site Atlanta Georgia 30342 United States Details
GSK Investigational Site Augusta Georgia 30912 United States Details
GSK Investigational Site Savannah Georgia 31405 United States Details
GSK Investigational Site Hinsdale Illinois 60521 United States Details
GSK Investigational Site Zion Illinois 60099 United States Details
GSK Investigational Site Fort Wayne Indiana 46845 United States Details
GSK Investigational Site Indianapolis Indiana 46202 United States Details
GSK Investigational Site Indianapolis Indiana 46260 United States Details
GSK Investigational Site Iowa City Iowa 52242-1009 United States Details
GSK Investigational Site Lexington Kentucky 40536 United States Details
GSK Investigational Site Covington Louisiana 70433 United States Details
GSK Investigational Site New Orleans Louisiana 70121 United States Details
GSK Investigational Site Shreveport Louisiana 71103 United States Details
GSK Investigational Site Boston Massachusetts 02114 United States Details
GSK Investigational Site Springfield Massachusetts 01199 United States Details
GSK Investigational Site Detroit Michigan 48201 United States Details
GSK Investigational Site Saint Louis Missouri 63110 United States Details
GSK Investigational Site Lebanon New Hampshire 03756 United States Details
GSK Investigational Site Albuquerque New Mexico 87131 United States Details
GSK Investigational Site Rio Rancho New Mexico 87124 United States Details
GSK Investigational Site Albany New York 12208 United States Details
GSK Investigational Site Bronx New York 10461 United States Details
GSK Investigational Site New York New York 10016 United States Details
GSK Investigational Site Charlotte North Carolina 28204 United States Details
GSK Investigational Site Durham North Carolina 27710 United States Details
GSK Investigational Site Kernersville North Carolina 27284 United States Details
GSK Investigational Site Mount Airy North Carolina 27030 United States Details
GSK Investigational Site Winston-Salem North Carolina 27103 United States Details
GSK Investigational Site Cincinnati Ohio 45219 United States Details
GSK Investigational Site Cincinnati Ohio 45220 United States Details
GSK Investigational Site Cleveland Ohio 44106 United States Details
GSK Investigational Site Columbus Ohio 43210 United States Details
GSK Investigational Site Tulsa Oklahoma 74146 United States Details
GSK Investigational Site Philadelphia Pennsylvania 19111 United States Details
GSK Investigational Site Pittsburgh Pennsylvania 15224 United States Details
GSK Investigational Site Willow Grove Pennsylvania 19090 United States Details
GSK Investigational Site Providence Rhode Island 02905 United States Details
GSK Investigational Site Knoxville Tennessee 37920 United States Details
GSK Investigational Site Austin Texas 78731 United States Details
GSK Investigational Site Dallas Texas 75246 United States Details
GSK Investigational Site Fort Worth Texas 76104 United States Details
GSK Investigational Site Charlottesville Virginia 22903 United States Details
GSK Investigational Site Roanoke Virginia 24016 United States Details
GSK Investigational Site Seattle Washington 98109 United States Details
GSK Investigational Site Grodno 230030 Belarus Details
GSK Investigational Site Minsk 223040 Belarus Details
GSK Investigational Site Aalst 9300 Belgium Details
GSK Investigational Site Leuven 3000 Belgium Details
GSK Investigational Site Liège 4000 Belgium Details
GSK Investigational Site Calgary Alberta T2N 4N2 Canada Details
GSK Investigational Site Winnipeg Manitoba R3E 0V9 Canada Details
GSK Investigational Site Ottawa Ontario K1H 8L6 Canada Details
GSK Investigational Site Sault Ste. Marie Ontario P6B 0A8 Canada Details
GSK Investigational Site Toronto Ontario M5G 2M9 Canada Details
GSK Investigational Site Montreal Quebec H4A 3J1 Canada Details
GSK Investigational Site Montréal Quebec H2X 3E4 Canada Details
GSK Investigational Site Quebec G1R 2J6 Canada Details
GSK Investigational Site Brno 625 00 Czechia Details
GSK Investigational Site Prague 128 00 Czechia Details
GSK Investigational Site Aalborg 9100 Denmark Details
GSK Investigational Site Copenhagen DK-2100 Denmark Details
GSK Investigational Site Dk-2730 Herlev 2730 Denmark Details
GSK Investigational Site Odense 5000 Denmark Details
GSK Investigational Site Kuopio 70210 Finland Details
GSK Investigational Site Tampere 33520 Finland Details
GSK Investigational Site Turku 20520 Finland Details
GSK Investigational Site Karlsruhe Baden-Wuerttemberg 76135 Germany Details
GSK Investigational Site Ravensburg Baden-Wuerttemberg 88212 Germany Details
GSK Investigational Site Tuebingen Baden-Wuerttemberg 72076 Germany Details
GSK Investigational Site Ulm Baden-Wuerttemberg 89075 Germany Details
GSK Investigational Site Amberg Bayern 92224 Germany Details
GSK Investigational Site Muenchen Bayern 81675 Germany Details
GSK Investigational Site Rosenheim Bayern 83022 Germany Details
GSK Investigational Site Bad Homburg Hessen 61352 Germany Details
GSK Investigational Site Giessen Hessen 35385 Germany Details
GSK Investigational Site Offenbach Hessen 63069 Germany Details
GSK Investigational Site Wiesbaden Hessen 65189 Germany Details
GSK Investigational Site Hannover Niedersachsen 30177 Germany Details
GSK Investigational Site Essen Nordrhein-Westfalen 45136 Germany Details
GSK Investigational Site Essen Nordrhein-Westfalen 45147 Germany Details
GSK Investigational Site Koeln Nordrhein-Westfalen 50935 Germany Details
GSK Investigational Site Mainz Rheinland-Pfalz 55131 Germany Details
GSK Investigational Site Dessau Sachsen-Anhalt 06847 Germany Details
GSK Investigational Site Dresden Sachsen 01307 Germany Details
GSK Investigational Site Kiel Schleswig-Holstein 24105 Germany Details
GSK Investigational Site Luebeck Schleswig-Holstein 23538 Germany Details
GSK Investigational Site Jena Thueringen 07747 Germany Details
GSK Investigational Site Hamburg 20246 Germany Details
GSK Investigational Site Hamburg 20259 Germany Details
GSK Investigational Site Athens 115 22 Greece Details
GSK Investigational Site Thessaloniki 54645 Greece Details
GSK Investigational Site Budapest 1122 Hungary Details
GSK Investigational Site Debrecen 4032 Hungary Details
GSK Investigational Site Ashkelon 78278 Israel Details
GSK Investigational Site Beer Sheva 84101 Israel Details
GSK Investigational Site Haifa 3436212 Israel Details
GSK Investigational Site Jerusalem 91120 Israel Details
GSK Investigational Site Petach Tikva 4941492 Israel Details
GSK Investigational Site Rehovot 76100 Israel Details
GSK Investigational Site Tel Aviv 64239 Israel Details
GSK Investigational Site Carpi (MO) Emilia-Romagna 41012 Italy Details
GSK Investigational Site Sassuolo Emilia-Romagna 41049 Italy Details
GSK Investigational Site Udine Friuli-Venezia-Giulia 33100 Italy Details
GSK Investigational Site Roma Lazio 00128 Italy Details
GSK Investigational Site Roma Lazio 00144 Italy Details
GSK Investigational Site Milano Lombardia 20133 Italy Details
GSK Investigational Site Candiolo Piemonte 10060 Italy Details
GSK Investigational Site Lecce Puglia 73100 Italy Details
GSK Investigational Site Trento Trentino-Alto Adige 38122 Italy Details
GSK Investigational Site Ponderano 13875 Italy Details
GSK Investigational Site Amsterdam 1105 AZ Netherlands Details
GSK Investigational Site Eindhoven 5623 EJ Netherlands Details
GSK Investigational Site Enschede 7512 KZ Netherlands Details
GSK Investigational Site Groningen 9713 GZ Netherlands Details
GSK Investigational Site Maastricht 6229 HX Netherlands Details
GSK Investigational Site Rotterdam 3015 GD Netherlands Details
GSK Investigational Site Bergen 5021 Norway Details
GSK Investigational Site Oslo 0310 Norway Details
GSK Investigational Site Stavanger 4011 Norway Details
GSK Investigational Site Tromso 9019 Norway Details
GSK Investigational Site Trondheim 7006 Norway Details
GSK Investigational Site Bialystok 15-207 Poland Details
GSK Investigational Site Gdynia 81-519 Poland Details
GSK Investigational Site Lodz 93-513 Poland Details
GSK Investigational Site Olsztyn 10-228 Poland Details
GSK Investigational Site Poznan 60-569 Poland Details
GSK Investigational Site Szczecin 70-111 Poland Details
GSK Investigational Site Warszawa 00-909 Poland Details
GSK Investigational Site Madrid Navarra 28027 Spain Details
GSK Investigational Site Barcelona 08036 Spain Details
GSK Investigational Site Barcelona 8035 Spain Details
GSK Investigational Site Cordoba 14004 Spain Details
GSK Investigational Site Madrid 28041 Spain Details
GSK Investigational Site Málaga 29010 Spain Details
GSK Investigational Site San Sebastián 20014 Spain Details
GSK Investigational Site Sevilla 41014 Spain Details
GSK Investigational Site Valencia 46010 Spain Details
GSK Investigational Site Linköping SE-581 85 Sweden Details
GSK Investigational Site Lund 222 42 Sweden Details
GSK Investigational Site Stockholm SE-171 76 Sweden Details
GSK Investigational Site Uppsala SE-751 85 Sweden Details
GSK Investigational Site Adapazari 54290 Turkey Details
GSK Investigational Site Ankara 06230 Turkey Details
GSK Investigational Site Istanbul 34093 Turkey Details
GSK Investigational Site Istanbul 34098 Turkey Details
GSK Investigational Site Istanbul 34147 Turkey Details
GSK Investigational Site Chernihiv 14029 Ukraine Details
GSK Investigational Site Kharkiv 61024 Ukraine Details
GSK Investigational Site Truro Cornwall TR1 3LJ United Kingdom Details
GSK Investigational Site Brighton BN2 5BE United Kingdom Details
GSK Investigational Site Cambridge CB2 0QQ United Kingdom Details
GSK Investigational Site London NW1 2PG United Kingdom Details
GSK Investigational Site London SE1 9RT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field